Protein crystallography and fragment-based drug design

Area of Science:

• Biochemistry
• Structural Biology
• Drug Discovery

Background:

• Crystallography is crucial for structure-driven drug design, providing 3D protein and complex structures.
• Traditional crystallography has limitations for high-throughput drug discovery.
• Recent advancements aim to overcome these limitations.

Purpose of the Study:

• To review achievements in protein crystallography over the last 5 years.
• To examine the advantages and disadvantages of fragment-based drug discovery using X-ray crystallography.
• To present case studies of recent drug discovery efforts.

Main Methods:

• Review of recent literature on protein crystallography and fragment-based drug discovery.
• Analysis of experimental and computational tools and protocols.
• Detailed examination of five recent therapeutic case studies.

Main Results:

• Significant advances in automated crystallization, data collection, phasing, and ligand fitting.
• Fragment-based screening using X-ray crystallography reduces drug discovery timelines.
• Successful application in developing new hits/leads for cancer, immune response, inflammation, metabolic syndrome, and neurology.

Conclusions:

• Protein crystallography continues to be a vital tool for drug design.
• Fragment-based approaches, enhanced by crystallographic techniques, are effective for lead discovery.
• Recent case studies demonstrate the clinical relevance and potential of these methods.